Publications by authors named "Karin Pat"

Claim this Profile
L
Long-term outcomes of preoperative nivolumab with or without relatlimab in patients with resectable non-small-cell lung cancer (NEOpredict-Lung).
Kristof Cuppens, Marcel Wiesweg, Paul Baas, Brigitte Maes, Bert Du Pont, Karin Pat

Eur J Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sjögren's Syndrome Caused by PD-1 Inhibition in a Lung Cancer Patient.
Aaron Caeyman, Olivia Vandekerckhove, Karin Pat, Jokke Wynants, Karolien Weytjens

Case Rep Oncol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liquid Biopsy in Early-Stage Lung Cancer: Current and Future Clinical Applications.
Olivia Vandekerckhove, Kristof Cuppens, Karin Pat, Bert Du Pont, Guy Froyen

Cancers (Basel)· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective, multicenter, noninterventional study of decision factors in the first-line treatment of metastatic non-small cell lung cancer.
Anne Sibille, Frederique Bustin, Luciano Carestia, Gaetan Catala, Christophe Compère, Karin Pat

Acta Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real life safety and effectiveness of nivolumab in older patients with non-small cell lung cancer: Results from the Belgian compassionate use program.
Sofie Joris, Thierry Pieters, Anne Sibille, Fréderique Bustin, Laurence Jacqmin, Karin Pat

J Geriatr Oncol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triple Trouble: A Case of Multiple Resistance Mechanisms after First Generation EGFR-TKI in NSCLC.
Mike Ralki, Brigitte Maes, Karin Pat, Jokke Wynants, Kristof Cuppens

Case Rep Oncol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does nivolumab for progressed metastatic lung cancer fulfill its promises? An efficacy and safety analysis in 20 general hospitals.
Kurt G Tournoy, Michiel Thomeer, Paul Germonpré, Sofie Derijcke, Rebecca De Pauw, Karin Pat, Patrick Alexander

Lung Cancer· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation and Application of a Custom-Designed Targeted Next-Generation Sequencing Panel for the Diagnostic Mutational Profiling of Solid Tumors.
Guy Froyen, An Broekmans, Femke Hillen, Karin Pat, Ruth Achten

PLoS One· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Study protocol of KLIMOP: a cohort study on the wellbeing of older cancer patients in Belgium and the Netherlands.
Laura Deckx, Doris van Abbema, Katherine Nelissen, Liesbeth Daniels, Piet Stinissen, Karin Pat

BMC Public Health· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic review of symptom control and quality of life in studies on chemotherapy for advanced non-small cell lung cancer: how CONSORTed are the data?
Karin Pat, Christophe Dooms, Johan Vansteenkiste

Lung Cancer· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Flexible dosing with Darbepoetin alfa for the treatment of chemotherapy-induced anemia.
Isabelle Wauters, Karin Pat, Johan Vansteenkiste

Ther Clin Risk Manag· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of chemotherapy on symptom control and quality of life in patients with advanced non-small cell lung cancer.
Christophe A Dooms, Karin E Pat, Johan F Vansteenkiste

Expert Rev Anticancer Ther· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis